Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Alkermes Q4 Earnings Call Highlights
02:38am, Saturday, 28'th Feb 2026
Alkermes (NASDAQ: ALKS) executives highlighted a "strong and eventful" 2025 and outlined a 2026 plan focused on expanding the company's commercial platform following its Avadel acquisition while advan
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
12:40pm, Thursday, 26'th Feb 2026
ALKS beats Q4 earnings and revenue estimates, but shares fall 7%. The company announces a CEO transition plan.
Alkermes (ALKS) Reports Q4 Earnings: What Key Metrics Have to Say
01:30pm, Wednesday, 25'th Feb 2026
While the top- and bottom-line numbers for Alkermes (ALKS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compa
Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates
01:15pm, Wednesday, 25'th Feb 2026
Alkermes (ALKS) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $1.04 per share a year ago.
Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript
12:47pm, Wednesday, 25'th Feb 2026
Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
07:00am, Wednesday, 25'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter and year ended Dec. 31, 2025 and provided financial expectations for 2026. To view the detailed fo
Alkermes plc Announces CEO Succession Plan
06:55am, Wednesday, 25'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) (Alkermes) today announced that Richard Pops will retire from his role as Chief Executive Officer (CEO), effective July 31, 2026. Alkermes' Board o
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
04:00pm, Tuesday, 24'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at
Wall Street's Insights Into Key Metrics Ahead of Alkermes (ALKS) Q4 Earnings
10:15am, Tuesday, 24'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for Alkermes (ALKS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Pre-Market Stock Futures: Futures are trading higher this morning after a dreadful day to start the trading week. Various reasons were cited for the risk-off bias on Monday, but the tariff situation,
Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?
10:42am, Wednesday, 18'th Feb 2026
Here is how Alkermes (ALKS) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 17'th Feb 2026
Alkermes (ALKS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
07:30am, Thursday, 12'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel”) today announced Alkermes' completion of its acquisition of Avadel, a
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
04:00pm, Wednesday, 11'th Feb 2026
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company's fourth qu
Federated Hermes Inc. Sells 19,313 Shares of Alkermes plc $ALKS
04:56am, Tuesday, 10'th Feb 2026
Federated Hermes Inc. reduced its stake in shares of Alkermes plc (NASDAQ: ALKS) by 84.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange
